Salud financiera de hoja de balance de Proto Labs
Salud financiera controles de criterios 6/6
Proto Labs tiene un patrimonio de accionistas total de $680.0M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $753.8M y $73.8M respectivamente. El BAIT de Proto Labs es de $29.8M, por lo que su ratio de cobertura de intereses es de -13.6. Tiene efectivo e inversiones a corto plazo que ascienden a $100.5M.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | -13.6x |
| Efectivo | US$100.51m |
| Patrimonio | US$679.99m |
| Total pasivo | US$73.79m |
| Activos totales | US$753.79m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Proto Labs' (NYSE:PRLB) Performance Is Even Better Than Its Earnings Suggest
Nov 14
Proto Labs, Inc.'s (NYSE:PRLB) 36% Jump Shows Its Popularity With Investors
Nov 02Here's What's Concerning About Proto Labs' (NYSE:PRLB) Returns On Capital
Sep 08Proto Labs: Defensive Strategy Not Paying Off Yet
Aug 13Calculating The Intrinsic Value Of Proto Labs, Inc. (NYSE:PRLB)
Jul 18Proto Labs: Interesting Crossroads
May 28Proto Labs' (NYSE:PRLB) Solid Earnings Are Supported By Other Strong Factors
May 11Proto Labs, Inc.'s (NYSE:PRLB) Price In Tune With Revenues
Apr 13Proto Labs: Cash Flows Are Supporting The Stock
Mar 04Proto Labs: Excellent Business Feats Yet To Financially Materialize
Feb 16Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital
Jan 03Proto Labs: Overlooked Digital Manufacturing Opportunity
Dec 04Proto Labs Remains Profitable Despite So Much Pessimism
Sep 25Proto Labs: The Rally Appears Overdone
Jul 14Be Wary Of Proto Labs (NYSE:PRLB) And Its Returns On Capital
Jul 13Is There An Opportunity With Proto Labs, Inc.'s (NYSE:PRLB) 41% Undervaluation?
May 06Proto Labs (NYSE:PRLB) Might Be Having Difficulty Using Its Capital Effectively
Apr 08Proto Labs Non-GAAP EPS of $0.26 beats by $0.05, revenue of $115.6M beats by $5.47M
Feb 10Proto Labs: Transitioning From A Fast Grower To A Slow Grower
Jan 20Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Dec 21Proto Labs Q3 2022 Earnings Preview
Nov 03Proto Labs: Improvement Of The Digital Model And Undervalued
Oct 27Is It Too Late To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?
Sep 12Protolabs names new technology chief
Sep 08Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 05Proto Labs Q2 2022 Earnings Preview
Aug 04Proto Labs: Not A Great Prospect Until Profitability Issues Clear Up
Jul 07Is Proto Labs, Inc. (NYSE:PRLB) Potentially Undervalued?
May 24Proto Labs (NYSE:PRLB) Could Be Struggling To Allocate Capital
Mar 30The Prognosis For Proto Labs
Feb 22Returns On Capital At Proto Labs (NYSE:PRLB) Paint A Concerning Picture
Nov 28Is There Now An Opportunity In Proto Labs, Inc. (NYSE:PRLB)?
Nov 10Proto Labs: A Play On Additive Manufacturing
Nov 04Investors Could Be Concerned With Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 29Some Investors May Be Willing To Look Past Proto Labs' (NYSE:PRLB) Soft Earnings
Aug 14Estimating The Fair Value Of Proto Labs, Inc. (NYSE:PRLB)
Aug 04Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($193.1M) de PRLB superan a sus pasivos a corto plazo ($53.8M).
Pasivo a largo plazo: Los activos a corto plazo de PRLB ($193.1M) superan a sus pasivos a largo plazo ($20.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: PRLB está libre de deudas.
Reducción de la deuda: PRLB no tenía deudas hace 5 años.
Cobertura de la deuda: PRLB no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.
Cobertura de intereses: PRLB no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.